Osage University Partners

Osage University Partners

A Pennsylvania based venture capital fund founded in 2009.

Osage University Partners (OUP) is a Pennsylvania venture capital firm founded in 2009.

OUP seeks to invest in companies founded by scientists, academics and students in software, hardware, therapeutics, medical devices and diagnostics sectors.

The company's portfolio includes Artizan Biosciences, Cleave Therapeutics, Cyteir Therapeutics, Everactive, IonQ, Landos Biopharma, Menlo Security, Menlo Security, PMV Pharmaceuticals and SiFive, etc.

OUP manages $600M and is investing out of a $273M fund as of November 2019.

Timeline

2009

Founded

Funded Companies

Company
Description
Website
Industry
Location

Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.

U.S-based Cisco subsidiary designing fabless silicon photonics semiconductors.

Vor BioPharma is a biotechnology company developing hematopoietic stem cell therapy treatments for cancer.

A research and development company for miRNA-directed treatments for cancer and other diseases

A clinical research organization that gives services to rising pharmaceutical, biotechnology and medical device companies

A company that develops molecular imaging agents to detect and monitor chronic human diseases

SolarBridge Technologies is an Austin, Texas-based electronics company.

A company focused on developing treatments for immune diseases

An immunotherapy company developing approaches to enable the body's immune system to fight against diseases

SiFive is a San Francisco-based company founded by Krste Asanović.

A biopharmaceutical company focused on developing treatments for inner and middle ear diseases

NuMat Technologies is a company founded by Benjamin Hernandez.

A company dedicated on the discovery and development of small molecule therapeutics to treat cancer

PsiKick is a sensor company.

A company developing small molecule inhibitors of arginase and serotonin therapeutics for pulmonary and critical cases

A pharmaceutical company focused on developing products for the treatment of glaucoma

45 Results
Page 1 of 2
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Kirsten Leute

Senior Vice President of University Relations

Louis Berneman

Founding Partner

Marc Singer

Managing Partner

Robert Adelson

Managing Partner & Co-Founder

Anurag Agarwal

Senior Associate Life Science

Beth Grafstrom

Vice President of Finance

Bill Harrington

Managing Partner

Britt Kennett

Executive Assistant

Claudia Dunnous

Chief Financial Officer

David Dorsey

Senior Associate Technology

Elan Cramer

Analyst

Jaimie Testai

Best Practices Manager University Relations

John Lee

Principal Technology

Kumar Patel

Senior Fund Accountant Finance

Manny Stockman

Principal Technology

Matthew Cohen

Partner

Natasha Azar

Senior Manager of University Relations

University Relations

Stephanie Stehman

Principal Life Science

Further reading

Title
Author
Link
Type
Date

Osage University Partners Raises Third Fund For University Research Spinouts

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Artizan Biosciences

Cleave Therapeutics

Cyteir Therapeutics

Everactive

IonQ

Landos Biopharma

Menlo Security

Menlo Security

PMV Pharmaceuticals

SiFive

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.